CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Pre-Mkt 09-04 08:56:51 EDT

2.20

+0.10

+4.76%

盘前2.25

+0.05+2.27%

08:38 EDT

High2.27	Low2.12	Vol94.78K
Open2.12	D1 Closing2.10	Amplitude7.38%
Mkt Cap15.02M	Tradable Cap8.72M	Total Shares6.83M
T/O209.49K	T/O Rate2.39%	Tradable Shares3.96M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":2.2,"timestamp":1788465600000,"preClose":2.1,"halted":0,"volume":94776,"hourTrading":{"tag":"盘前","latestPrice":2.25,"preClose":2.2,"latestTime":"08:38 EDT","volume":228,"amount":498.460326,"timestamp":1788525480123,"change":0.05,"changeRate":0.022727,"amplitude":0.033636},"delay":0,"changeRate":0.04761904761904766,"floatShares":3962980,"shares":6828300,"eps":-6.65276,"marketStatus":"Pre-Mkt","change":0.1,"latestTime":"09-04 08:56:51 EDT","open":2.115,"high":2.27,"low":2.115,"amount":209487.11749679997,"amplitude":0.07381,"askPrice":2.4,"askSize":60,"bidPrice":1.99,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.65276,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.25,"preClose":2.2,"latestTime":"08:38 EDT","volume":228,"amount":498.460326,"timestamp":1788525480123,"change":0.05,"changeRate":0.022727,"amplitude":0.033636},"postHourTrading":{"tag":"盘后","latestPrice":2.186,"preClose":2.2,"latestTime":"19:30 EDT","volume":10909,"amount":23174.066,"timestamp":1788478206750,"change":-0.014,"changeRate":-0.006364,"amplitude":0.040909},"volumeRatio":0.5530218509003988,"impliedVol":1.8027,"impliedVolPercentile":0.9063},"requestUrl":"/m/hq/s/CALC/tweets","defaultTab":"tweets","newsList":[{"id":"2664814418","title":"CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:47","pubTimestamp":1788353251,"startTime":"0","endTime":"0","summary":"An update from CalciMedica ( ($CALC) ) is now available. On August 31, 2026, CalciMedica reported that Nasdaq staff determined the company now sati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-addresses-nasdaq-equity-compliance-amid-bid-price-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-addresses-nasdaq-equity-compliance-amid-bid-price-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","CALC","LCLG","BK4215","EQR","BK4588","NQmain","REZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811422","title":"CalciMedica Implements 1-for-5 Reverse Stock Split to Address NASDAQ $1 Minimum Bid Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811422","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811422?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:31","pubTimestamp":1788352319,"startTime":"0","endTime":"0","summary":"CalciMedica implements 1-for-5 reverse stock split to address Nasdaq $1 minimum bid ruleCalciMedica implemented a 1-for-5 reverse stock split at 5:00 p.m. ET on Aug. 28, 2026.Move followed a Nasdaq no","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbN042B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663197680","title":"NASDAQ Trade Halt Continues Halt News Pending at 08:59 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2663197680","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663197680?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:59","pubTimestamp":1787965188,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUESHALT NEWS PENDING AT 08:59 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260829:nAQN2MH5GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019340","title":"Calcimedica Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019340?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:55","pubTimestamp":1787961310,"startTime":"0","endTime":"0","summary":"19:50 EDT Calcimedica (CALC) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088947","title":"CalciMedica to effect 1-for-5 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088947?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:16","pubTimestamp":1787836566,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5, effective...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-to-effect-1-for-5-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-to-effect-1-for-5-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700178","title":"CalciMedica Announces One-for-Five Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700178?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:00","pubTimestamp":1787835601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA8N6TNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287968","title":"CalciMedica Price Target Announced at $9.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287968?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:22","pubTimestamp":1787232120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660833232","title":"CalciMedica Shareholders Approve 7.5 Million-Share Increase to Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660833232","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660833232?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:03","pubTimestamp":1787220205,"startTime":"0","endTime":"0","summary":"CalciMedica shareholders approve 7.5 million-share increase to equity incentive planCalciMedica held its annual shareholder meeting on Aug. 19, 2026.Shareholders backed an amended 2023 equity incentiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3xQnXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660400516","title":"CalciMedica initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2660400516","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660400516?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:15","pubTimestamp":1787217317,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of CalciMedica (CALC) with a Buy rating and $9 price target The firm is positive on the company’s CM5480, a first-in-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901648","title":"Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901648?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:00","pubTimestamp":1786554032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XBI","LABU","XLV","NXTC","LU0128526141.USD","HCSG","LU0029874061.USD","BK4585","CALC","BK4581","BK4588","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918265","title":"CalciMedica Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918265","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918265?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:50","pubTimestamp":1786452654,"startTime":"0","endTime":"0","summary":"CalciMedica Inc reports results for the quarter ended June 30 - Earnings SummaryCalciMedica IncCALC.OQreported a quarterly adjusted loss of 45 cents per share for the quarter ended June 30, lower than","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44816G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927979","title":"CalciMedica Q2 EPS $(0.45) Misses $(0.28) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927979","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927979?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:28","pubTimestamp":1786447725,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.28) by 60.71 percent. This is a 12.5 percent decrease over losses of $(0.40) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61103854/calcimedica-q2-eps-0-45-misses-0-28-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992563","title":"CalciMedica Q2 FY26 Net Loss Widens to $7.65 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992563","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992563?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:08","pubTimestamp":1786446492,"startTime":"0","endTime":"0","summary":"CalciMedica Q2 FY26 net loss widens to $7.65 millionCalciMedica posted a Q2 net loss of USD 7.65 million, widening from a USD 5.96 million loss a year earlier; loss per share widened to USD 0.45 from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4XTbrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994237","title":"CalciMedica Q2 Basic EPS USD -0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994237?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLXCPS681:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992331","title":"Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992331?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"CalciMedica announced a private placement of up to approximately. $49 million in gross proceeds, including approximately $15 million in. upfront gross proceeds. The proceeds are expected to support the. advancement of Auxora and CM5480 as part of the Company's pulmonary. -- Auxora Phase 1b proof-of-concept trial in PAH planned: CalciMedica plans. to evaluate Auxora in a Phase 1b trial in patients with pulmonary. arterial hypertension to generate initial clinical evidence regarding the. effects of CRAC channel inhibition on pulmonary vascular and right. -- CM5480 preclinical and IND-enabling studies advancing: Studies are. ongoing to further characterize the pharmacology, pharmacokinetics, and. safety profile of CM5480, CalciMedica's oral CRAC channel inhibitor. candidate for chronic use in PH. Preclinical data suggest CM5480 may be. differentiated by directly protecting right ventricular function, a key","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AP","CALC","BK4555","TM","BK4006","LU0417517546.SGD","BK4580","LU0070302665.USD","BK4588","BK4585","LU0208291251.USD","LU2264538146.SGD","BK4007","LU1989772840.SGD","CRAC","LU0211331839.USD","LU1989772923.USD","LU0256863902.USD","BK4604","03160","PH","BK4161","BK4099","LU0320765489.SGD","LU1988902786.USD","LU1064131342.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657472676","title":"CalciMedica Inc Expected to Post a Loss of 28 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657472676","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657472676?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:06","pubTimestamp":1786118764,"startTime":"0","endTime":"0","summary":"CalciMedica Inc <CALC.OQ> expected to post a loss of28cents a share - Earnings PreviewCalciMedica IncCALC.OQCALC.Ois expected to  show no change in quarterly revenue when it reports  results on August 10  for the period ending June 30 2026LSEG's mean analyst estimate for CalciMedica Inc is for a loss of 28 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for CalciMedica Inc is $10.50, about 1,374.7% above its last closing price of $0.71This summary was machine generated August 7 at 16:06 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N444210:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655899723","title":"CalciMedica announces FDA alignment on Phase 2b Auxora trial design","url":"https://stock-news.laohu8.com/highlight/detail?id=2655899723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655899723?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:40","pubTimestamp":1785336017,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced that, following a Type C Focused Meeting, the U.S. Food and Drug Administration and the company have aligned on Phase ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-fda-alignment-on-phase-2b-auxora-trial-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-fda-alignment-on-phase-2b-auxora-trial-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","LABU","BK4588","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655753899","title":"CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2655753899","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655753899?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:35","pubTimestamp":1785335738,"startTime":"0","endTime":"0","summary":"FDA alignment on CalciMedica’s (CALC) acute pancreatitis program for Auxora de-risks the regulatory path, validating Phase 2b endpoint selection an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-fda-alignment-de-risks-regulatory-path-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-fda-alignment-de-risks-regulatory-path-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","CALC","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655189938","title":"CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2655189938","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655189938?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:08","pubTimestamp":1785334119,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) said Wednesday it has reached alignment with the US Food and Drug Administration on the endpoints and patient selection criteria for a planned phase 2b trial of Auxora in acute panc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CALC","LABU","BK4588","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655864895","title":"CalciMedica - Expects Ind Submission for Cm5480 in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2655864895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655864895?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://calcimedica.com;ir.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.0638},{"period":"1month","weight":-0.4465},{"period":"3month","weight":-0.5849},{"period":"6month","weight":-0.3948},{"period":"1year","weight":-0.8634},{"period":"ytd","weight":-0.9332}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CalciMedica, Inc. was incorporated in February 2015 under the laws of Delaware. The company is a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases driven by inflammatory and immune processes as well as direct cellular damage. Its product candidates target calcium release-activated calcium (\"CRAC\") channels and would constitute a new class of drugs.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093409},{"month":2,"riseRate":0,"avgChangeRate":-0.254297},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.215568},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.035007},{"month":5,"riseRate":0.5,"avgChangeRate":0.045995},{"month":6,"riseRate":0.5,"avgChangeRate":0.058885},{"month":7,"riseRate":0.333333,"avgChangeRate":0.138093},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.157543},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.001295},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.333333,"avgChangeRate":0.111978},{"month":12,"riseRate":0.666667,"avgChangeRate":0.040206}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}